FDA.reportPublic FDA data

1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]

RxCUI
1086259
RxNorm name
1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]
Display name
TRIESENCE (Injectable)
Full name
1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]
Term type
SBD
Status
Active
Strength
40 mg/ml
Dose form
Injection 1 ml
Route
Injectable
Updated
2026-06-14 07:05:37

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022011
Active start
022011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
triamcinolone acetonide40 MG / 1 MLtriamcinolonetriamcinolone acetonide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
triamcinolone10759

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STR1 ML Triesence 40 MG/ML InjectionNAMES
RxNorm Name1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]NAMES
RxNorm Synonym1 ML Triesence 40 MG/ML InjectionNAMES
RxNorm SynonymTriesence 40 MG per 1 ML InjectionNAMES
TTYSBDATTRIBUTES
SPL_SET_ID2267978c-72ad-9229-e063-6394a90a09d0CODES
SPL_SET_ID22692d92-1359-9252-e063-6394a90ab669CODES
RxCUI1086259CODES
MMSL_CODEBD31448CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0078-0897-780078-0897TRIESENCE triamcinolone acetonideNovartis Pharmaceuticals CorporationNDA022048
82667-800-0182667-800TRIESENCE triamcinolone acetonideHarrow Eye, LLCNDA022048

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA0220480078-0897TRIESENCE triamcinolone acetonideNDANovartis Pharmaceuticals Corporation

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00065054301rxnav_ndcsyes
00078089778rxnav_ndcsyes
82667080001rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TRIESENCETRIAMCINOLONE ACETONIDEHarrow Eye, LLC2267978c-72ad-9229-e063-6394a90a09d02026-06-05Warnings, Adverse reactionsExact identifier
ndc (package): 82667-800-01
ndc (product): 82667-800
ndc11 (package): 82667080001
rxcui: 1086259
TRIESENCETRIAMCINOLONE ACETONIDENovartis Pharmaceuticals Corporation22692d92-1359-9252-e063-6394a90ab6692026-04-01Warnings, Adverse reactionsExact identifier
ndc (package): 0078-0897-78
ndc (product): 0078-0897
ndc11 (package): 00078089778
rxcui: 1086259

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2267978c-72ad-9229-e063-6394a90a09d01 ML Triesence 40 MG/ML InjectionSY3These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720251030
2267978c-72ad-9229-e063-6394a90a09d0Triesence 40 MG in 1 ML InjectionPSN3These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720251030
2267978c-72ad-9229-e063-6394a90a09d01 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]SBD3These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720251030
2267978c-72ad-9229-e063-6394a90a09d0Triesence 40 MG per 1 ML InjectionSY3These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720251030
22692d92-1359-9252-e063-6394a90ab669Triesence 40 MG in 1 ML InjectionPSN2These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720260401
22692d92-1359-9252-e063-6394a90ab669Triesence 40 MG per 1 ML InjectionSY2These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720260401
22692d92-1359-9252-e063-6394a90ab6691 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]SBD2These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720260401
22692d92-1359-9252-e063-6394a90ab6691 ML Triesence 40 MG/ML InjectionSY2These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720260401

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
2267978c-72ad-9229-e063-6394a90a09d0These highlights do not include all the information needed to use TRIESENCE safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957Harrow Eye, LLC | Alcon Research LLC20260605
22692d92-1359-9252-e063-6394a90ab669These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957Novartis Pharmaceuticals Corporation | Alcon Research LLC20260401
2267978c-72ad-9229-e063-6394a90a09d0These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957Harrow Eye, LLC | Alcon Research LLC20251030
3f045347-3e5e-4bbd-90f8-6c3100985ca5These highlights do not include all the information needed to use TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE ® suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957Alcon Laboratories, Inc. | Alcon Research LLC20240916
2267978c-72ad-9229-e063-6394a90a09d0These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957Harrow Eye, LLC20240916
153f36e3-58f9-4d0a-88d8-aaf3e2593269National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC05AACorticosteroidsATC1-4triamcinolone
ATCR01ADCorticosteroidsATC1-4triamcinolone
ATCA01ACCorticosteroids for local oral treatmentATC1-4triamcinolone
ATCD07ABCorticosteroids, moderately potent (group II)ATC1-4triamcinolone
ATCD07XBCorticosteroids, moderately potent, other combinationsATC1-4triamcinolone
ATCS01BACorticosteroids, plainATC1-4triamcinolone
ATCR03BAGlucocorticoidsATC1-4triamcinolone
ATCH02ABGlucocorticoidsATC1-4triamcinolone
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone acetonide
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone acetonide
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone
MEDRTD014221TriamcinoloneCHEMhas_ingredienttriamcinolone
MEDRTD014222Triamcinolone AcetonideCHEMhas_ingredienttriamcinolone acetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone acetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone acetonide
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone acetonide
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone acetonide
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone acetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone acetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone acetonide
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone acetonide
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone acetonide
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone acetonide
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone acetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone
MEDRTD007239InfectionsDISEASEci_withtriamcinolone acetonide
MEDRTD007239InfectionsDISEASEci_withtriamcinolone
MEDRTD007249InflammationDISEASEmay_treattriamcinolone acetonide
MEDRTD007249InflammationDISEASEmay_treattriamcinolone
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone acetonide
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone acetonide
MEDRTD009181MycosesDISEASEci_withtriamcinolone
MEDRTD009181MycosesDISEASEci_withtriamcinolone acetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone acetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone acetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone acetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone acetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone acetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone acetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone acetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone acetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone acetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone acetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone acetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone acetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone acetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone acetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone acetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone acetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone acetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone acetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone acetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone acetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_petriamcinolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_petriamcinolone acetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_petriamcinolone acetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_petriamcinolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_petriamcinolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_petriamcinolone acetonide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_petriamcinolone acetonide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_petriamcinolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_petriamcinolone acetonide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH40 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESQUANTITY1 ML
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD31448
CODESNDANDA022048
CODESRxCUI1086259
CODESSPL_SET_ID2267978c-72ad-9229-e063-6394a90a09d0
CODESSPL_SET_ID22692d92-1359-9252-e063-6394a90ab669
NAMESPrescribable SynonymTriesence 40 MG in 1 ML Injection
NAMESRXNAV_STR1 ML Triesence 40 MG/ML Injection
NAMESRxNorm Name1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]
NAMESRxNorm Synonym1 ML Triesence 40 MG/ML Injection
NAMESRxNorm SynonymTriesence 40 MG per 1 ML Injection
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon